Using reverse docking for target identification and its applications for drug discovery

ABSTRACT Introduction: In contrast to traditional molecular docking, inverse or reverse docking is used for identifying receptors for a given ligand among a large number of receptors. Reverse docking can be used to discover new targets for existing drugs and natural compounds, explain polypharmacology and the molecular mechanism of a substance, find alternative indications of drugs through drug repositioning, and detecting adverse drug reactions and drug toxicity. Areas covered: In this review, the authors examine how reverse docking methods have evolved over the past fifteen years and how they have been used for target identification and related applications for drug discovery. They discuss various aspects of target databases, reverse docking tools and servers. Expert opinion: There are several issues related to reverse docking methods such as target structure dataset construction, computational efficiency, how to include receptor flexibility, and most importantly, how to properly normalize the docking scores. In order for reverse docking to become a truly useful tool for the drug discovery, these issues need to be adequately resolved.

[1]  Jian Zhang,et al.  Peptide deformylase is a potential target for anti‐Helicobacter pylori drugs: Reverse docking, enzymatic assay, and X‐ray crystallography validation , 2006, Protein science : a publication of the Protein Society.

[2]  Richard D. Taylor,et al.  Improved protein–ligand docking using GOLD , 2003, Proteins.

[3]  Yi Wang,et al.  In silico search of putative adverse drug reaction related proteins as a potential tool for facilitating drug adverse effect prediction. , 2006, Toxicology letters.

[4]  Rahmad Akbar,et al.  Interaction of ganoderic acid on HIV related target: molecular docking studies , 2011, Bioinformation.

[5]  Zhiwei Cao,et al.  Insight into potential toxicity mechanisms of melamine: an in silico study. , 2011, Toxicology.

[6]  Carlos Ortega-Zuñiga,et al.  Searching of protein targets for alpha lipoic acid , 2011 .

[7]  Haoyang Cai,et al.  ACTP: A webserver for predicting potential targets and relevant pathways of autophagy-modulating compounds , 2016, Oncotarget.

[8]  Peng Zhan,et al.  "Old friends in new guise": exploiting privileged structures for scaffold re-evolution/refining. , 2014, Combinatorial chemistry & high throughput screening.

[9]  Ruixin Zhu,et al.  Calmodulin as a Potential Target by Which Berberine Induces Cell Cycle Arrest in Human Hepatoma Bel7402 Cells , 2013, Chemical biology & drug design.

[10]  Joannis Apostolakis,et al.  GlamDock: Development and Validation of a New Docking Tool on Several Thousand Protein-Ligand Complexes , 2007, J. Chem. Inf. Model..

[11]  L. Meijer,et al.  Inverse in silico screening for identification of kinase inhibitor targets. , 2007, Chemistry & biology.

[12]  Xiaomin Luo,et al.  PDTD: a web-accessible protein database for drug target identification , 2008, BMC Bioinformatics.

[13]  J M Blaney,et al.  A geometric approach to macromolecule-ligand interactions. , 1982, Journal of molecular biology.

[14]  Michel F Sanner,et al.  FLIPDock: Docking flexible ligands into flexible receptors , 2007, Proteins.

[15]  Feng Xu,et al.  Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information , 2015, Nucleic Acids Res..

[16]  J. Olivero-Verbel,et al.  Theoretical targets for TCDD: a bioinformatics approach. , 2010, Chemosphere.

[17]  Y. Z. Chen,et al.  Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation , 2006, British journal of pharmacology.

[18]  Gang Fu,et al.  PubChem Substance and Compound databases , 2015, Nucleic Acids Res..

[19]  Z Zhang,et al.  Wentilactone B induces G2/M phase arrest and apoptosis via the Ras/Raf/MAPK signaling pathway in human hepatoma SMMC-7721 cells , 2013, Cell Death and Disease.

[20]  N. Paul,et al.  Recovering the true targets of specific ligands by virtual screening of the protein data bank , 2004, Proteins.

[21]  Xiaomin Luo,et al.  TarFisDock: a web server for identifying drug targets with docking approach , 2006, Nucleic Acids Res..

[22]  Didier Rognan,et al.  In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors. , 2006, Journal of medicinal chemistry.

[23]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[24]  Matthias Rarey,et al.  Facing the Challenges of Structure-Based Target Prediction by Inverse Virtual Screening , 2014, J. Chem. Inf. Model..

[25]  M. Lindsay Finding new drug targets in the 21st century. , 2005, Drug discovery today.

[26]  Baris E. Suzek,et al.  The Universal Protein Resource (UniProt) in 2010 , 2009, Nucleic Acids Res..

[27]  Thomas Lengauer,et al.  Fully Automated Flexible Docking of Ligands into Flexible Synthetic Receptors Using Forward and Inverse Docking Strategies , 2006, J. Chem. Inf. Model..

[28]  Raquel Hontecillas,et al.  Computational Modeling-Based Discovery of Novel Classes of Anti-Inflammatory Drugs That Target Lanthionine Synthetase C-Like Protein 2 , 2012, PloS one.

[29]  G. Klebe Virtual ligand screening: strategies, perspectives and limitations , 2006, Drug Discovery Today.

[30]  Vincent Le Guilloux,et al.  fpocket: online tools for protein ensemble pocket detection and tracking , 2010, Nucleic Acids Res..

[31]  Allen G. Rodrigo,et al.  A Statistical Model to Identify Differentially Expressed Proteins in 2D PAGE Gels , 2009, PLoS Comput. Biol..

[32]  Ruohua Chen,et al.  Ophiobolin O Isolated from Aspergillus ustus Induces G1 Arrest of MCF-7 Cells through Interaction with AKT/GSK3β/Cyclin D1 Signaling , 2015, Marine drugs.

[33]  Yang-Hua Yi,et al.  Two new bioactive triterpene glycosides from the sea cucumber Pseudocolochirus violaceus , 2006, Journal of Asian natural products research.

[34]  Didier Rognan,et al.  Ranking Targets in Structure-Based Virtual Screening of Three-Dimensional Protein Libraries: Methods and Problems , 2008, J. Chem. Inf. Model..

[35]  Dan Zhang,et al.  Bicyclol promotes toll-like 2 receptor recruiting inosine 5′-monophosphate dehydrogenase II to exert its anti-inflammatory effect , 2016, Journal of Asian natural products research.

[36]  Weiliang Zhu,et al.  New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery , 2006, Drug Discovery Today: Technologies.

[37]  Mire Zloh,et al.  Target fishing and docking studies of the novel derivatives of aryl-aminopyridines with potential anticancer activity. , 2012, Bioorganic & medicinal chemistry.

[38]  Lin He,et al.  DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome , 2011, Nucleic Acids Res..

[39]  George Papadatos,et al.  ChEMBL web services: streamlining access to drug discovery data and utilities , 2015, Nucleic Acids Res..

[40]  Jinyong Peng,et al.  Cytotoxicity of berberine on human cervical carcinoma HeLa cells through mitochondria, death receptor and MAPK pathways, and in-silico drug-target prediction. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[41]  Jing Zhao,et al.  Identification of Molecular Target Proteins in Berberine‐treated Cervix Adenocarcinoma HeLa Cells by Proteomic and Bioinformatic Analyses , 2012, Phytotherapy research : PTR.

[42]  Tuan-sheng Chen,et al.  A Comparative Reverse Docking Strategy to Identify Potential Antineoplastic Targets of Tea Functional Components and Binding Mode , 2011, International journal of molecular sciences.

[43]  De-An Guo,et al.  Proteomics Characterization of the Cytotoxicity Mechanism of Ganoderic Acid D and Computer-automated Estimation of the Possible Drug Target Network*S , 2008, Molecular & Cellular Proteomics.

[44]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[45]  Biplab Bhattacharjee,et al.  Comparative reverse screening approach to identify potential anti-neoplastic targets of saffron functional components and binding mode. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[46]  Paul N. Mortenson,et al.  Diverse, high-quality test set for the validation of protein-ligand docking performance. , 2007, Journal of medicinal chemistry.

[47]  Mire Zloh,et al.  Insights into mechanism of anticancer activity of pentacyclic oxindole alkaloids of Uncaria tomentosa by means of a computational reverse virtual screening and molecular docking approach , 2014, Monatshefte für Chemie - Chemical Monthly.

[48]  Yuri Pevzner,et al.  Virtual Target Screening: Validation Using Kinase Inhibitors , 2012, J. Chem. Inf. Model..

[49]  X. Chen,et al.  TTD: Therapeutic Target Database , 2002, Nucleic Acids Res..

[50]  Yong Xu,et al.  A combined molecular docking-based and pharmacophore-based target prediction strategy with a probabilistic fusion method for target ranking. , 2013, Journal of molecular graphics & modelling.

[51]  Xin Chen,et al.  The interprotein scoring noises in glide docking scores , 2012, Proteins.

[52]  平山 令明,et al.  PDB (Protein Data Bank)とその周辺 , 1996 .

[53]  Honglin Li,et al.  Fast and effective identification of the bioactive compounds and their targets from medicinal plants via computational chemical biology approach , 2011 .

[54]  Honglin Li,et al.  [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. , 2009, Cancer research.

[55]  Kai Huang,et al.  PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach , 2010, Nucleic Acids Res..

[56]  Chih Lee,et al.  Searching for transcription factor binding sites in vector spaces , 2012, BMC Bioinformatics.

[57]  Y.Z. Chen,et al.  Ligand–protein inverse docking and its potential use in the computer search of protein targets of a small molecule , 2001, Proteins.

[58]  David S. Goodsell,et al.  AutoDockFR: Advances in Protein-Ligand Docking with Explicitly Specified Binding Site Flexibility , 2015, PLoS Comput. Biol..

[59]  Minho Lee,et al.  Large-scale reverse docking profiles and their applications , 2012, BMC Bioinformatics.

[60]  P. Clemons,et al.  Target identification and mechanism of action in chemical biology and drug discovery. , 2013, Nature chemical biology.

[61]  Y. Z. Chen,et al.  Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach. , 2001, Journal of molecular graphics & modelling.

[62]  Vivek Kumar,et al.  In silico identification of targets for a novel scaffold, 2-thiazolylimino-5-benzylidin-thiazolidin-4-one , 2015, Molecular Diversity.

[63]  Xin Li,et al.  Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach , 2012, BMC Systems Biology.

[64]  Didier Rognan,et al.  Structure‐Based Approaches to Target Fishing and Ligand Profiling , 2010, Molecular informatics.

[65]  T. Cui,et al.  Cyclic diguanylate monophosphate directly binds to human siderocalin and inhibits its antibacterial activity , 2015, Nature Communications.

[66]  Yogesh T Jasrai,et al.  Prediction of protein targets of kinetin using in silico and in vitro methods: a case study on spinach seed germination mechanism , 2015, Journal of chemical biology.

[67]  Zhi-Wei Cao,et al.  Proteomic characterization of the possible molecular targets of pyrrolizidine alkaloid isoline-induced hepatotoxicity. , 2012, Environmental toxicology and pharmacology.

[68]  Xiaoqin Yang,et al.  Expression Profiling Identifies Bezafibrate as Potential Therapeutic Drug for Lung Adenocarcinoma , 2015, Journal of Cancer.

[69]  Jung-Hsin Lin,et al.  idTarget: a web server for identifying protein targets of small chemical molecules with robust scoring functions and a divide-and-conquer docking approach , 2012, Nucleic Acids Res..

[70]  Jessica Holien,et al.  Improvements, trends, and new ideas in molecular docking: 2012–2013 in review , 2015, Journal of molecular recognition : JMR.

[71]  Kailin Tang,et al.  Pathway-pathway network-based study of the therapeutic mechanisms by which salvianolic acid B regulates cardiovascular diseases , 2012 .

[72]  J. Irwin,et al.  Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.

[73]  Yi Wang,et al.  DITOP: drug-induced toxicity related protein database , 2007, Bioinform..

[74]  Didier Rognan,et al.  sc-PDB: a 3D-database of ligandable binding sites—10 years on , 2014, Nucleic Acids Res..

[75]  Lin He,et al.  Harvesting Candidate Genes Responsible for Serious Adverse Drug Reactions from a Chemical-Protein Interactome , 2009, PLoS Comput. Biol..

[76]  Tom Halgren,et al.  New Method for Fast and Accurate Binding‐site Identification and Analysis , 2007, Chemical biology & drug design.

[77]  Jing Zhao,et al.  Therapeutic Effects of Astragaloside IV on Myocardial Injuries: Multi-Target Identification and Network Analysis , 2012, PloS one.

[78]  Min Yang,et al.  Clarifying the signal network of salvianolic acid B using proteomic assay and bioinformatic analysis , 2011, Proteomics.